AI assistant
Sending…
HARROW, INC. — Director's Dealing 2007
Dec 27, 2007
31774_dirs_2007-12-27_d00e5dc0-32b1-4561-b1d4-d56f6a8349cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP)
CIK: 0001360214
Period of Report: 2007-12-27
Reporting Person: Singh Juliet (Director, President and CEO, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.001 per share | 1953125 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option (Right to Buy) | $2.00 | 2017-09-16 | Common Stock (200000) | Direct | |
| Option (Right to Buy) | $2.00 | 2017-09-16 | Common Stock (10000) | Direct |
Footnotes
F1: The options vest, in three equal annual installment beginning on September 17, 2008.
More from HARROW, INC.
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 8